Lysosome-Targeting Nanochimeras Attenuating Liver Fibrosis by Interconnected Transforming Growth Factor-β Reduction and Activin Receptor-Like Kinase 5 DegradationHanshu Liu, Hongxia Liang, Hanqing Chen et al.|ACS Nano|2025Cited by 18
SAT-049 Harnessing antioxidant nano-chimeras for combining targeted transforming growth factor β receptor I degradation and transforming growth factor β reduction to attenuate liver fibrosisHanshu Liu, Longdi Wang, Hongxia Liang et al.|Journal of Hepatology|2025Cited by 0